Solid Biosciences Inc. ($SLDB)
Filing Information
| Accession Number | 0001193125-26-034076 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Jan 29, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
440,450
Total Value
$168,968.62
P&L
+inf% (+$1,815,600.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Technology Officer | Common Stock | โ | Jan 29, 2026 | Exercise/Conversion | 54,925 | โ | โ | 81,547 | Direct | โ | View Details | |
Chief Technology Officer | Common Stock | โ | Jan 31, 2026 | Exercise/Conversion | 24,675 | โ | โ | 106,222 | Direct | โ | View Details | |
Chief Technology Officer | Common Stock | โ | Feb 2, 2026 | Sale | 26,250 | $6.44 | $168,968.62 | 79,972 | Direct | โ | View Details | |
Chief Technology Officer | Performance Stock Units | Derivative | Jan 29, 2026 | Exercise/Conversion | 54,925 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Technology Officer | Employee Stock Option (Right to Buy) | Derivative | Jan 29, 2026 | Grant/Award | 170,000 | $0.00 | $0.00 | 170,000 | Direct | โ | View Details | |
Chief Technology Officer | Restricted Stock Units | Derivative | Jan 29, 2026 | Grant/Award | 85,000 | $0.00 | $0.00 | 85,000 | Direct | โ | View Details | |
Chief Technology Officer | Restricted Stock Units | Derivative | Jan 31, 2026 | Exercise/Conversion | 24,675 | $0.00 | $0.00 | 74,025 | Direct | โ | View Details |